Pathomolecular effects of homocysteine on the aging process: a new theory of aging.
Homocysteine has been associated with the most common age-related diseases but never associated with the acceleration of the aging process. This theoretical paper will try to demonstrate the pro-aging effects of homocysteine at the molecular, cellular, and organ level. High homocysteine levels in homocystinuria are associated with premature disease of the cardiovascular, skeletal, neurological, and other systems. These observations are similar to those noted in the aging process and should be considered as a progeroid syndrome. There is enough scientific evidence to support that homocysteine accelerates the aging process at the cellular and at the organism level. Most importantly, decreasing homocysteine levels by dietary or pharmacological interventions could prolong maximum life span in humans and/or delay the onset of the most common age-related diseases.
Perez
Felipe P
FP
Geriatric Medicine Section, Department of Medicine, University of Illinois, College of Medicine, M/C 717, 840 South Wood Street, Chicago, IL 60612, USA. fperez04@uic.edu
Ilie
John I
JI
Zhou
Ximing
X
Feinstein
Douglas
D
Jurivich
Donald A
DA
D000375:Aging / Q000187:drug effects* / Q000502:physiology*; D000818:Animals; D006710:Homocysteine / Q000008:administration & dosage* / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological
D006710:Homocysteine